Shufeng Zhou, MD & PhD
Shufeng Zhou, MD & PhD
Professor & Dean, Huaqiao University
在 的电子邮件经过验证 - 首页
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
Autophagy 12 (1), 1-222, 2016
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part II
SF Zhou
Clinical Pharmacokinetics 48 (12), 761-804, 2009
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I
SF Zhou
Clinical Pharmacokinetics 48 (11), 689-723, 2009
Herb-drug interactions
Z Hu, X Yang, PCL Ho, SY Chan, PWS Heng, E Chan, W Duan, HL Koh, ...
Drugs 65 (9), 1239-1282, 2005
Polymorphism of human cytochrome P450 enzymes and its clinical impact
SF Zhou, JP Liu, B Chowbay
Drug Metabolism Reviews 41 (2), 89-295, 2009
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
SF Zhou
Xenobiotica 38 (7-8), 802-832, 2008
Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4
SF Zhou
Current Drug Metabolism 9 (4), 310-322, 2008
Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs
S Zhou, SY Chan, BC Goh, E Chan, W Duan, M Huang, HL McLeod
Clinical Pharmacokinetics 44 (3), 279-304, 2005
Herbal modulation of Pglycoprotein
S Zhou, LY Lim, B Chowbay
Drug Metabolism Reviews 36 (1), 57-104, 2004
Interactions of herbs with cytochrome P450
S Zhou, Y Gao, W Jiang, M Huang, A Xu, JW Paxton
Drug Metabolism Reviews 35 (1), 35-98, 2003
Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes
JS Bian, QC Yong, TT Pan, ZN Feng, MY Ali, S Zhou, PK Moore
Journal of Pharmacology and Experimental Therapeutics 316 (2), 670-678, 2006
Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development
SF Zhou, LL Wang, YM Di, CC Xue, W Duan, CG Li, Y Li
Current Medicinal Chemistry 15 (20), 1981-2039, 2008
Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring
SF Zhou, CC Xue, XQ Yu, C Li, G Wang
Therapeutic Drug Monitoring 29 (6), 687-710, 2007
Herbal bioactivation: the good, the bad and the ugly
S Zhou, HL Koh, Y Gao, Z Gong, EJD Lee
Life Sciences 74 (8), 935-968, 2004
Effects of Ganopoly® (A ganoderma lucidum polysaccharide extract) on the immune functions in AdvancedStage cancer patients
Y Gao, S Zhou, W Jiang, M Huang, X Dai
Immunological Investigations 32 (3), 201-215, 2003
New perspectives on how to discover drugs from herbal medicines: CAM's outstanding contribution to modern therapeutics
SY Pan, SF Zhou, SH Gao, ZL Yu, SF Zhang, MK Tang, JN Sun, DL Ma, ...
Evidence-Based Complementary and Alternative Medicine 2013, 2013
Pharmacokinetic interactions of drugs with St John’s wort
S Zhou, E Chan, SQ Pan, M Huang, EJD Lee
Journal of Psychopharmacology 18 (2), 262-276, 2004
Drug bioactivation covalent binding to target proteins and toxicity relevance
S Zhou, E Chan, W Duan, M Huang, YZ Chen
Drug Metabolism Reviews 37 (1), 41-213, 2005
Clinical pharmacogenetics and potential application in personalized medicine
SF Zhou, Y Ming Di, E Chan, YM Du, VDW Chow, CC Xue, X Lai, ...
Current Drug Metabolism 9 (8), 738-784, 2008
Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation
LL Wang, Z Zhang, Q Li, R Yang, X Pei, Y Xu, J Wang, SF Zhou, Y Li
Human Reproduction 24 (3), 562-579, 2009
文章 1–20